This is a double-blind, randomized, placebo-controlled, 4-period, cross-over clinical trial. The study is designed to evaluate the safety and local tolerability of DA-6034 upon single and repeated-dose topical application to the both eyes in healthy volunteers.

Corrected visual acuity less than 20/40 in either eye at the screening

Any eye surgery or laser eye surgery within the past six months

Intraocular pressure greater than 22 mmHg in either eye at the screening

Break-up time less than 10 sec with OSDI score corresponding to mild to severe dry eye symptoms in either eye at the screening

Unanesthetized Schirmer scores <10 mm in either eye at the screening

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01162954